Ge, J., Cheng, X., Yuan, C., Qian, J., Wu, C., Cao, C., . . . Zou, J. (2020). Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway. Int J Biol Sci.

Ge, Jun, Xiaoqiang Cheng, Chenxi Yuan, Jiale Qian, Chunshen Wu, Cheng Cao, Huilin Yang, Feng Zhou, and Jun Zou. "Syndecan-4 Is a Novel Therapeutic Target for Intervertebral Disc Degeneration Via Suppressing JNK/p53 Pathway." Int J Biol Sci 2020.

Ge, Jun, et al. "Syndecan-4 Is a Novel Therapeutic Target for Intervertebral Disc Degeneration Via Suppressing JNK/p53 Pathway." Int J Biol Sci 2020.